Publicacións (77) Publicacións de FERNANDO DOMINGUEZ PUENTE

2023

  1. Targets, Mechanisms and Cytotoxicity of Half-Sandwich Ir(III) Complexes Are Modulated by Structural Modifications on the Benzazole Ancillary Ligand

    Cancers, Vol. 15, Núm. 1

2022

  1. Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

    Advanced Functional Materials, Vol. 32, Núm. 29

2021

  1. A Simple Entropic-Driving Separation Procedure of Low-Size Silver Clusters, Through Interaction with DNA

    ChemistryOpen, Vol. 10, Núm. 8, pp. 760-763

  2. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e1077-e1089

2019

  1. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells

    Chemical Communications, Vol. 55, Núm. 8, pp. 1140-1143

2018

  1. Silver Atomic Quantum Clusters of Three Atoms for Cancer Therapy: Targeting Chromatin Compaction to Increase the Therapeutic Index of Chemotherapy

    Advanced Materials, Vol. 30, Núm. 33

  2. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes

    Inorganic Chemistry, Vol. 57, Núm. 22, pp. 14322-14336

  3. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity

    European Journal of Medicinal Chemistry, Vol. 157, pp. 279-293

2015

  1. Ag2 and Ag3 Clusters: Synthesis, Characterization, and Interaction with DNA

    Angewandte Chemie - International Edition, Vol. 54, Núm. 26, pp. 7612-7616

  2. Interaction of silver atomic quantum clusters with living organisms: bactericidal effect of Ag3 clusters mediated by disruption of topoisomerase-DNA complexes

    Chemical Science, Vol. 6, Núm. 12, pp. 6717-6724

  3. Monomer-dimer divergent behavior toward DNA in a half-sandwich ruthenium(II) aqua complex. Antiproliferative biphasic activity

    Organometallics, Vol. 34, Núm. 1, pp. 319-327

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

2012

  1. Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin

    PLoS ONE, Vol. 7, Núm. 10

2011

  1. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis

    Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188

  2. Synthesis, structure, and biological activity of des-side Chain analogues of 1α,25-Dihydroxyvitamin D3 with substituents at C18

    ChemMedChem, Vol. 6, Núm. 5, pp. 788-793

2010

  1. Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin.

    Journal of controlled release : official journal of the Controlled Release Society, Vol. 148, Núm. 1

  2. Functional consequences of seven novel mutations in the CYP11B1 gene: Four mutations associated with nonclassic and three mutations causing classic 11β-hydroxylase deficiency

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 2, pp. 779-788

  3. Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant

    BMC Genetics, Vol. 11

2009

  1. Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system.

    Human mutation, Vol. 30, Núm. 2

2008

  1. A new chemical tool (C0036E08) supports the role of adenosine A2B receptors in mediating human mast cell activation

    Biochemical Pharmacology, Vol. 76, Núm. 7, pp. 912-921